文献速递瓣膜外科

血液透析患者主动脉瓣置换:生物瓣与机械瓣中期结局比较

Intermediate-term outcomes of aortic valve replacement with bioprosthetic or mechanical valves in patients on hemodialysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-09-28

日本18中心回顾性队列纳入2008—2015年491例慢性透析成人主动脉瓣置换患者,比较生物瓣(323例)与机械瓣(168例)中期结局。倾向评分校正后总生存无显著差异。

要点

  • 生物瓣与机械瓣住院死亡、5年总生存及免再手术率均无显著差异。
  • 倾向评分校正41项混杂因素后,两组总生存仍无显著差异。

核心结论

  • 透析患者主动脉瓣置换选用生物瓣或机械瓣,中期总生存无显著差异。

研究设计与样本

  • 日本18家机构多中心回顾性队列研究,纳入2008至2015年慢性透析成人主动脉瓣置换患者491例。
  • 生物瓣组323例,机械瓣组168例,平均随访2.5±2.1年(最长8.3年),随访完整率98%。
  • 采用Cox回归与Fine-Gray模型,基于41项混杂因素行倾向评分校正。

主要发现

  • 倾向评分校正分析显示两组总生存无显著差异。

临床怎么用

  • 透析患者主动脉瓣置换瓣膜类型选择可个体化,不必仅因中期生存差异强制选用某一类型。
  • 术前应告知透析患者主动脉瓣置换后中期生存率仍较低。

局限性

  • 回顾性设计,平均随访仅2.5±2.1年,中期结论需更长期验证。
  • 原文未报告再手术的具体原因及瓣膜相关并发症细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the influence of choice of prosthesis (bioprosthetic valves or mechanical valves) on intermediate-term outcomes in patients on hemodialysis undergoing aortic valve replacement (AVR). METHODS: A multi-institutional retrospective cohort study was conducted in 18 Japanese centers. All adult patients on chronic hemodialysis who underwent AVR from 2008 and 2015 were included (n = 491). The early and late results were compared between groups. The hazard ratios were calculated using Cox regression and Fine-Gray models with adjustment for propensity score based on 41 confounders. The mean follow-up period was 2.5 ± 2.1 years (up to 8.3 years) with 98% completeness. RESULTS: There were 323 patients who received a bioprosthetic valve (group B), and 168 patients who received a mechanical valve (group M). There was no significant difference for in-hospital death rate between groups (group B: 12.1%; group M: 8.9%; P = .29). The overall survival rate at 5 years after surgery was 39.3% in group B and 50.4% in group M (P = .42). Freedom from reoperation at 5 years was 97.1% in group B and 97.8% in group M (P = .88). On propensity-score adjusted analyses, there were no significant differences in overall survival between groups. CONCLUSIONS: There were no significant differences in overall survival between bioprosthetic valves and mechanical valves in patients on hemodialysis undergoing AVR.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nakatsu T, Minakata K, Tanaka S, et al. Intermediate-term outcomes of aortic valve replacement with bioprosthetic or mechanical valves in patients on hemodialysis. J Thorac Cardiovasc Surg. 2018. PMID: 31307139. doi:10.1016/j.jtcvs.2018.08.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。